المؤلفون: Alexandre Demoule, Jean-Jacques Tudesq, Alexandra Beurton, Muriel Fartoukh, Guillaume Geri, Romain Jouffroy, Safaa Nemlaghi, Antoine Vieillard-Baron, Michael Darmon, Elie Azoulay, Foucauld Isnard

المساهمون: Hôpital Ambroise Paré [AP-HP], Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Service des Urgences [CHU Tenon], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Service d'Anesthésie réanimation [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)

المصدر: Journal of Critical Care
Journal of Critical Care, WB Saunders, 2021, 64, pp.199-204. ⟨10.1016/j.jcrc.2021.04.014⟩

مصطلحات موضوعية: Male, medicine.medical_treatment, Hemodynamics, Critical Care and Intensive Care Medicine, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, Prone position, 0302 clinical medicine, Mechanical ventilation, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, MESH: Cannula, Intubation, MESH: COVID-19, MESH: Aged, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, MESH: Middle Aged, MESH: Paris, MESH: Patient Positioning, Middle Aged, Intensive Care Units, Anesthesia, MESH: Survival Analysis, High-flow nasal cannula, Breathing, Female, Respiratory Insufficiency, Paris, MESH: Hemodynamics, MESH: Blood Gas Analysis, Patient Positioning, Article, 03 medical and health sciences, medicine, Cannula, Humans, MESH: SARS-CoV-2, Propensity Score, Aged, Retrospective Studies, MESH: Humans, SARS-CoV-2, Proportional hazards model, business.industry, COVID-19, 030208 emergency & critical care medicine, Retrospective cohort study, MESH: Retrospective Studies, MESH: Prone Position, MESH: Propensity Score, Survival Analysis, MESH: Male, 030228 respiratory system, Respiratory failure, MESH: Intensive Care Units, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Blood Gas Analysis, business, MESH: Female, MESH: Respiratory Insufficiency

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e755c3beca3ebcc0404f812139efc3Test
http://europepmc.org/articles/PMC8087575Test

المؤلفون: Mehdi Totonchi, Mehri Mashayekhi, Ken McElreavey, Navid Almadani, Anu Bashambou, Arvand Akbari, Kimiya Padidar, Najmeh Salehi, Mohammad Ali Sadighi Gilani

المساهمون: Royan Institute for Reproductive Biomedicine [Tehran, Iran], Academic Center for Education, Culture and Research (ACECR), University of Tehran, Génétique du Développement humain - Human developmental genetics, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), This study was financially supported by Royan Institute, Tehran, Iran, and Institut Pasteur, Paris, France, We are sincerely thankful to the personnel of Royan Department of Genetics and the Human Developmental Genetics Unit of Institut Pasteur, Paris, France, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS)

المصدر: Human Reproduction
Human Reproduction, 2021, 36 (4), pp.1134-1145. ⟨10.1093/humrep/deaa362⟩
Human Reproduction, Oxford University Press (OUP), 2021, 36 (4), pp.1134-1145. ⟨10.1093/humrep/deaa362⟩

مصطلحات موضوعية: Male, Proband, 46, XX Disorders of Sex Development, [SDV]Life Sciences [q-bio], Cell Cycle Proteins, Iran, MESH: Mice, Knockout, Mice, non-obstructive azoospermia, Missense mutation, MESH: Animals, Exome sequencing, Mice, Knockout, Sanger sequencing, Genetics, 0303 health sciences, MESH: Paris, 030305 genetics & heredity, Rehabilitation, Obstetrics and Gynecology, oligozoospermia, DNA-Binding Proteins, symbols, Female, primary gonadal failure, France, Paris, dbSNP, familial exome sequencing, Biology, 03 medical and health sciences, symbols.namesake, MESH: Cell Cycle Proteins, Animals, Humans, MESH: Mice, Gene, Retrospective Studies, 030304 developmental biology, Disorder of Sex Development, 46,XY, MESH: Humans, MESH: Retrospective Studies, MSH4, MESH: Male, primary ovarian insufficiency, MESH: France, MSH5, Reproductive Medicine, MESH: Iran, MESH: Female, MESH: DNA-Binding Proteins

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fbb6fadc8926a4bf1f45ebf363194abTest
https://doi.org/10.1093/humrep/deaa362Test

المؤلفون: Laurence Ma, Valérie Briolat, Imène Najjar, Marc Monot, Laure Lemée, Laurence Motreff

المساهمون: Pôle Biomics (C2RT), Centre de Ressources et de Recherche Technologique - Center for Technological Resources and Research (C2RT), Institut Pasteur [Paris]-Institut Pasteur [Paris], The Biomics platform is supported by France Génomique (ANR-10-INBS-09-09) and Infrastructures en Biologie, Santé et Agronomie (IBiSA). This work was supported by the 'URGENCE COVID-19' fundraising campaign of IP., We thank the other members of Biomics who made it possible for the activities of the platform to continue during lockdown: Julian Garneau, Elodie Turc, George Haustant, Zachary Allouche, Thomas Cockelear, Juliana Pipoli Da Fonseca, and Etienne Kornobis. We would particularly like to thank our collaborator from the IP of Tunis Sadri Znaidi and the C2RT Head of Operations Anna Kheres for taking the time to read the manuscript and for giving recommendations and advice. The authors declare no conflicts of interest., ANR-10-INBS-0009,France-Génomique,Organisation et montée en puissance d'une Infrastructure Nationale de Génomique(2010), Institut Pasteur [Paris] (IP)-Institut Pasteur [Paris] (IP)

المصدر: Journal of Biomolecular Techniques
Journal of Biomolecular Techniques, Association of Biomolecular Resource Facilities, 2021, 32 (2), pp.jbt.21-3202-004. ⟨10.7171/jbt.21-3202-004⟩
Journal of Biomolecular Techniques, 2021, 32 (2), pp.jbt.21-3202-004. ⟨10.7171/jbt.21-3202-004⟩
J Biomol Tech

مصطلحات موضوعية: Paris, MESH: Pandemics, Process management, Quality management, [SDV]Life Sciences [q-bio], coronavirus, Risk management information systems, Crisis management, Article, MESH: Communicable Disease Control, Business continuity, Added value, Humans, MESH: COVID-19, MESH: SARS-CoV-2, Pandemics, Molecular Biology, MESH: High-Throughput Nucleotide Sequencing, MESH: Humans, Emergency management, business.industry, SARS-CoV-2, MESH: Paris, COVID-19, High-Throughput Nucleotide Sequencing, Benchmarking, OMICS sequencing, 3. Good health, Core Facility, NGS, Communicable Disease Control, MESH: Laboratories, Business, Laboratories, management

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59af9b736315eb6b037f620ed76ba460Test
https://hal-pasteur.archives-ouvertes.fr/pasteur-03371253Test

المؤلفون: Gaymard, Alexandre, Bosetti, Paolo, Feri, Adeline, Destras, Gregory, Enouf, Vincent, Andronico, Alessio, Burrel, Sonia, Behillil, Sylvie, Sauvage, Claire, Bal, Antonin, Morfin, Florence, Van Der Werf, Sylvie, Josset, Laurence, Blanquart, François, Coignard, Bruno, Cauchemez, Simon, Lina, Bruno, Gault, Elyanne, Moreau, Frédérique, Brichler, Ségolène, Delagrèverie, Héloïse, Descamps, Diane, Charpentier, Charlotte, Rozenberg, Flore, L'Honneur, Anne-Sophie, Veyer, David, Bélec, Laurent, Fourati, Slim, Rodriguez, Christophe, Pawlotsky, Jean-Michel, Fourgeaud, Jacques, Abid, Hanène, Roque-Afonso, Anne-Marie, Fenaux, Honorine, Jary, Aude, Marot, Stéphane, Salmona, Maud, Chaix, Marie-Laure, Morand-Joubert, Laurence, Schnuriger, Aurélie, Juillet, Stéphanie Marque, Bargain, Pauline, Poggi, Cécile, Chollet, Lionel, Guillaume, Clémence, Guinard, Jérôme, Vallet, Sophie, Pilorgé, Léa, Schvoerer, Evelyne, Hartard, Cédric, Castelain, Sandrine, François, Catherine, Ducancelle, Alexandra, Lefeuvre, Caroline, Lepiller, Quentin, Marty-Quinternet, Solène, Bellecave, Pantxika, Tumiotto, Camille, Dina, Julia, Le Gouil, Meriadeg, Henquell, Cécile, Mirand, Audrey, Césaire, Raymond, de Rougemont, Alexis, Auvray, Christelle, Larrat, Sylvie, Némoz, Benjamin, Tinez, Claire, Guigon, Aurélie, Hantz, Sébastien, Rogez, Sylvie, Dos Santos, Georges, Perez, Pascale, Jost, Christelle, Montes, Brigitte, Foulongne, Vincent, Imbert, Berthe-Marie, Bressollette, Céline, Giordanengo, Valérie, Gonfrier, Géraldine, Garcia, Magali, Lévêque, Nicolas, Brodard, Véronique, Moret, Hélène, Thibault, Vincent, Maillard, Anne, Jaffar-Bandjee, Marie-Christine, Gueudin, Marie, Plantier, Jean-Christophe, Pozzetto, Bruno, Pillet, Sylvie, Fafi-Kremer, Samira, Solis, Morgane, Izopet, Jacques, Trémeaux, Pauline, Stefic, Karl, Handala, Lynda, Billaud, Geneviève, Frobert, Emilie, Mérens, Audrey, Bigaillon, Christine, Desroches, Marine, Thepenier, Cédric, Janvier, Frédéric, Otto, Marie-Pierre, Roquebert, Bénédicte, Haïm-Boukobza, Stéphanie

المساهمون: Centre National de Référence des Virus des Infections Respiratoires (dont la Grippe) [Lyon] (CNR - laboratoire associé), Institut des Agents Infectieux [Lyon] (IAI), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Hospices Civils de Lyon (HCL), Virpath-Grippe, de l'émergence au contrôle -- Virpath-Influenza, from emergence to control (Virpath), Centre International de Recherche en Infectiologie (CIRI), École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure de Lyon (ENS de Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Modélisation mathématique des maladies infectieuses - Mathematical modelling of Infectious Diseases, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Direction des maladies infectieuses - Infectious Diseases Division [Saint-Maurice], Santé publique France - French National Public Health Agency [Saint-Maurice, France], Centre National de Référence des virus des infections respiratoires (dont la grippe) - National Reference Center Virus Influenzae [Paris] (CNR - laboratoire coordonnateur), Institut Pasteur [Paris] (IP), Génétique Moléculaire des Virus à ARN - Molecular Genetics of RNA Viruses (GMV-ARN (UMR_3569 / U-Pasteur_2)), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Centre interdisciplinaire de recherche en biologie (CIRB), Labex MemoLife, École normale supérieure - Paris (ENS-PSL), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Collège de France (CdF (institution))-Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris sciences et lettres (PSL)-École normale supérieure - Paris (ENS-PSL), Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, Agents infectieux, résistance et chimiothérapie - UR UPJV 4294 (AGIR ), Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie, Laboratoire de Virologie [CHU Amiens], CHU Amiens-Picardie, ANRS - Maladies infectieuses émergentes (ANRS - MIE), Institut National de la Santé et de la Recherche Médicale (INSERM), We acknowledge financial support from Santé publique France (the French national public health agency), the French Ministry of health (Grant COVIDseq), the Consortium for the surveillance and research on emerging pathogens via microbial genomics (EMERGEN) coordinated by Santé publique France and ANRS Maladies Infectieuses Emergentes, the Investissement d’Avenir programme, the Laboratoire d’Excellence Integrative Biology of Emerging Infectious Diseases programme (grant ANR-10-LABX-62-IBEID), the European Union’s Horizon 2020 research and in-novation programme under grants 101003589 (RECOVER). This work has been supported by the laboratories belonging to the ColVHB network*., ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), European Project: 101003589, H2020-SC1-PHE-CORONAVIRUS-2020,RECOVER(2020), Centre National de Référence des Virus des Infections Respiratoires (dont la Grippe) [Lyon] (CNR), Centre International de Recherche en Infectiologie - UMR (CIRI), École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Centre National de Référence des virus des infections respiratoires (dont la grippe) - National Reference Center Virus Influenzae [Paris] (CNR), Institut Pasteur [Paris], Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris sciences et lettres (PSL)-Collège de France (CdF (institution))-École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Collège de France (CdF (institution))-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)-Université Sorbonne Paris Nord, Gestionnaire, Hal Sorbonne Université, Integrative Biology of Emerging Infectious Diseases - - IBEID2010 - ANR-10-LABX-0062 - LABX - VALID, Rapid European COVID-19 Emergency Response research - RECOVER - - H2020-SC1-PHE-CORONAVIRUS-20202020-02-14 - 2022-02-13 - 101003589 - VALID, Institut National de la Santé et de la Recherche Médicale (INSERM)-École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-École normale supérieure - Lyon (ENS Lyon)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris sciences et lettres (PSL)-École normale supérieure - Paris (ENS Paris)

المصدر: Eurosurveillance
Eurosurveillance, 2021, 26 (9), ⟨10.2807/1560-7917.ES.2021.26.9.2100133⟩
Eurosurveillance, European Centre for Disease Prevention and Control, 2021, 26 (9), ⟨10.2807/1560-7917.ES.2021.26.9.2100133⟩

مصطلحات موضوعية: Author's Correction, Paris, medicine.medical_specialty, 2019-20 coronavirus outbreak, Lineage (genetic), Coronavirus disease 2019 (COVID-19), Epidemiology, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), viral infections, [SDV]Life Sciences [q-bio], Context (language use), Biology, 03 medical and health sciences, 0302 clinical medicine, Virology, medicine, Humans, MESH: COVID-19, MESH: SARS-CoV-2, 030212 general & internal medicine, 030304 developmental biology, COVID, [SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases, [SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology, 0303 health sciences, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, MESH: Humans, SARS-CoV-2, MESH: Paris, Public Health, Environmental and Occupational Health, COVID-19, [SDV] Life Sciences [q-bio], MESH: France, 20I/501Y.V1, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, surveillance, France, mutation, Rapid Communication, Demography

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72a8c8537e39c0714557c9422e8d1197Test
https://hal.sorbonne-universite.fr/hal-03184264Test

المؤلفون: Philippe Attias, Thomas Kofman, Nathanael Lapidus, Hamza Sakhi, Slim Fourati, Djamal Dahmane, Khalil El Karoui, Magali Bouvier

المساهمون: CHU Henri Mondor, Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Université Paris-Est Créteil Val-de-Marne - Faculté de médecine (UPEC Médecine), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Service de santé publique [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), HAL-SU, Gestionnaire

المصدر: Journal of the American Society of Nephrology
Journal of the American Society of Nephrology, American Society of Nephrology, 2021, 32 (5), pp.1033-1036. ⟨10.1681/ASN.2020111618⟩

مصطلحات موضوعية: Male, 0301 basic medicine, medicine.medical_treatment, 030232 urology & nephrology, serology, MESH: Spike Glycoprotein, Coronavirus, Antibodies, Viral, Gastroenterology, [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology, Serology, 0302 clinical medicine, MESH: Aged, 80 and over, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, MESH: Immunocompromised Host, Medicine, MESH: COVID-19, MESH: Coronavirus Nucleocapsid Proteins, MESH: Renal Dialysis, Aged, 80 and over, [SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases, MESH: Aged, MESH: Immunoglobulin G, education.field_of_study, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, hemodialysis, MESH: Middle Aged, biology, MESH: Kinetics, MESH: Paris, General Medicine, Middle Aged, 3. Good health, Titer, [SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology, Nephrology, MESH: Kidney Failure, Chronic, [SDV.IMM.IA] Life Sciences [q-bio]/Immunology/Adaptive immunology, Spike Glycoprotein, Coronavirus, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Female, Hemodialysis, Antibody, Adult, Paris, medicine.medical_specialty, MESH: Pandemics, MESH: Transplant Recipients, Population, MESH: Phosphoproteins, Immunocompromised Host, 03 medical and health sciences, Antigen, Renal Dialysis, Transplantation Immunology, Internal medicine, Coronavirus Nucleocapsid Proteins, Humans, MESH: SARS-CoV-2, Seroconversion, MESH: Transplantation Immunology, education, Pandemics, SARS-CoV-2 antibody, Aged, Retrospective Studies, MESH: Humans, business.industry, SARS-CoV-2, COVID-19, Retrospective cohort study, MESH: Adult, MESH: Retrospective Studies, Phosphoproteins, [SDV.MHEP.UN] Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology, Transplant Recipients, MESH: Male, Kinetics, 030104 developmental biology, Immunoglobulin G, biology.protein, Kidney Failure, Chronic, business, MESH: Female, MESH: Antibodies, Viral

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09f23369c1c3791c5929d49aa06b81bbTest
https://hal.sorbonne-universite.fr/hal-03251712Test

المؤلفون: Pierre Charneau, Philippe Souque, Evelyne Dufour, Marion Gransagne, Stéphane Petres, Ana Ines Lalanne, Thierry Rose, Isabelle Turbiez, François Dejardin, François Anna, Odile Richard-Le Goff, Olivier Helynck, Maude Guillot-Delost, Sophie Goyard, Alexia Savignoni, François-Clément Bidard, Zaineb Choucha, Fabien Nevo, Franck Perez, Delphine Louis, Véronique Gillon, Yves L. Janin, A Gobillion, Nicolas Escriou, Olivier Lantz

المساهمون: Laboratoire commun Pasteur-TheraVectys, Institut Pasteur [Paris]-TheraVectys, Biologie Cellulaire des Lymphocytes - Lymphocyte Cell Biology, Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Pasteur [Paris], Institut Curie [Paris], Virologie Moléculaire et Vaccinologie / Molecular Virology and Vaccinology, Institut Pasteur [Paris], Laboratoire d’innovation : vaccins – Innovation lab : vaccines, Risques cliniques et sécurité en santé des femmes et en santé périnatale (RISCQ), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Immunité et cancer (U932), Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Plateforme technologique Production et purification de protéines recombinantes – Production and Purification of Recombinant Proteins Technological Platform (PPR), Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Anticorps en thérapie et pathologie - Antibodies in Therapy and Pathology, Chimie et Biocatalyse, This work was made possible thanks to the financial support obtained through the URGENCE nouveau coronavirus fundraising campaign of Institut Pasteur and the financial support of the Fondation Total. This study was funded in part by a grant from Fondation de France and by Institut Curie Institutional funding. The luciferin synthesis development has been supported by DARRI (ValoExpress 2016-2018). LuLISA development has been supported by IARP Pasteur-Carnot MI (2019-2020)., Institut Pasteur [Paris] (IP)-TheraVectys, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pasteur [Paris] (IP), Université Paris-Saclay, Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Lassailly-Bondaz, Anne, Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Curie [Paris], Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur [Paris]

المصدر: European Journal of Immunology
European Journal of Immunology, 2021, 51 (1), pp.180-190. ⟨10.1101/2020.10.25.20219030⟩
European Journal of Immunology, Wiley-VCH Verlag, 2021, 51 (1), pp.180-190. ⟨10.1101/2020.10.25.20219030⟩

مصطلحات موضوعية: 0301 basic medicine, Male, Time Factors, Antibodies, Viral, SARS‐CoV‐2, MESH: Antibodies, Neutralizing, Serology, 0302 clinical medicine, Seroepidemiologic Studies, Epidemiology, MESH: COVID-19, Immunology and Allergy, 030212 general & internal medicine, Research Articles, MESH: Immunoglobulin G, 0303 health sciences, education.field_of_study, MESH: Paris, 3. Good health, Titer, Research Article|Basic, ELISA, Female, medicine.symptom, Bioluminescence, Adult, MESH: Pandemics, medicine.medical_specialty, Paris, Population, Immunology, Anosmia, Immunity to infection, Biology, Asymptomatic, Virus, 03 medical and health sciences, COVID‐19, Internal medicine, medicine, Humans, Basic, education, Pandemics, 030304 developmental biology, LuLISA, MESH: Seroepidemiologic Studies, MESH: Humans, SARS-CoV-2, business.industry, MESH: Time Factors, COVID-19, MESH: Adult, Ageusia, Antibodies, Neutralizing, MESH: Male, 030104 developmental biology, Immunization, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Immunoglobulin G, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business, MESH: Female, MESH: Antibodies, Viral, 030215 immunology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b59f4d153d34fd8d49f3c10edec5e1bTest

المؤلفون: Youri Yordanov, Aurelien Dinh, Patrick Jourdain, Erwan Debuc, Xavier Lescure, Agnès Dechartres, Caroline Apra, Pascaline Villie, Jerome Marchand-Arvier

المساهمون: Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Centre de Pharmacoépidémiologie de l'AP-HP (Cephepi), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service de Neurochirurgie [CHU Pitié-Salpêtrière], Service d'Urgences Adultes [CHU Saint-Antoine], CHU Saint-Antoine [AP-HP], Service des Maladies Infectieuses et Tropicales [CHU Raymond Poincaré], Hôpital Raymond Poincaré [AP-HP], AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), HAL-SU, Gestionnaire, Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service des Urgences [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)

المصدر: Journal of Medical Internet Research
Journal of Medical Internet Research, JMIR Publications, 2020, 22 (10), pp.e20748. ⟨10.2196/20748⟩
Journal of Medical Internet Research, Vol 22, Iss 10, p e20748 (2020)

مصطلحات موضوعية: Male, MESH: Coronavirus Infections, Health Status, MESH: Monitoring, Physiologic, 030204 cardiovascular system & hematology, 0302 clinical medicine, MESH: Health Surveys, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Pandemic, Health care, Outpatients, Medicine, MESH: COVID-19, 030212 general & internal medicine, app, MESH: Health Status, [SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, MESH: Middle Aged, lcsh:Public aspects of medicine, MESH: Paris, Middle Aged, Telemedicine, 3. Good health, coronavirus disease, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, lcsh:R858-859.7, MESH: Betacoronavirus, Female, [SDV.IB]Life Sciences [q-bio]/Bioengineering, Medical emergency, patient, Coronavirus Infections, Adult, 2019-20 coronavirus outbreak, Paris, MESH: Pandemics, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), infectious disease, Pneumonia, Viral, telesurveillance, Health Informatics, lcsh:Computer applications to medicine. Medical informatics, 03 medical and health sciences, Betacoronavirus, Viewpoint, Humans, home monitoring, MESH: SARS-CoV-2, Pandemics, Rapid response, Monitoring, Physiologic, [SDV.IB] Life Sciences [q-bio]/Bioengineering, MESH: Humans, business.industry, SARS-CoV-2, COVID-19, lcsh:RA1-1270, MESH: Adult, medicine.disease, Health Surveys, MESH: Male, MESH: Outpatients, monitoring, MESH: Pneumonia, Viral, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, MESH: Telemedicine, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business, MESH: Female

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35812c14e764cb690c7f67e7cc3f4c54Test
https://hal.sorbonne-universite.fr/hal-03099448/file/article.pdfTest

المؤلفون: Loïc de Pontual, Carine El Sissy, Felipe Suarez, Jérémie Rosain, Capucine Picard, Véronique Frémeaux-Bacchi, Paula Vieira Martins, Claire Fieschi, Muhamed-Kheir Taha, David Launay, Despina Moshous, Caroline Thomas, Eva Hong, Marie Ouachee, Ala-Eddine Deghmane

المساهمون: Service d'immunologie [HEGP, Paris], Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Centre National de Référence des Méningocoques et Haemophilus influenzae - National Reference Center Meningococci and Haemophilus influenzae (CNR), Institut Pasteur [Paris] (IP), Lille Inflammation Research International Center - U 995 (LIRIC), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Hôpitaux Universitaires de Paris Seine-Saint-Denis, Université Paris Descartes - Paris 5 (UPD5), Immunologie clinique [CHU St-Louis], Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Différenciation et progression tumorale des lymphocytes, École Pratique des Hautes Études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut Universitaire d'Hématologie (IUH), Université Paris Diderot - Paris 7 (UPD7)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Unité d'Hémato-Immunologie pédiatrique [Hôpital Robert Debré, Paris], Service d'Immuno-hématologie pédiatrique [Hôpital Robert Debré, Paris], Hôpital Robert Debré-Hôpital Robert Debré, Hématologie et oncologie pédiatrique, Centre hospitalier universitaire de Nantes (CHU Nantes), École des Mines de Saint-Étienne (Mines Saint-Étienne MSE), Institut Mines-Télécom [Paris] (IMT), Service d'immuno-hématologie pédiatrique [CHU Necker], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Imagine - Institut des maladies génétiques (IMAGINE - U1163), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Référence Déficits Immunitaires Héréditaires (CEREDIH), Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), This work was supported by Agence Régionale de Santé Ile-de-France ('Année Recherche' fellowship to J. R.), Institut Pasteur [Paris], Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), École pratique des hautes études (EPHE), Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Centre National de Référence des Méningocoques-Infections Bactériennes Invasives (CNR), Lille Inflammation Research International Center (LIRIC), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), École pratique des hautes études (EPHE)-Institut Universitaire d'Hématologie (IUH), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Necker - Enfants Malades [AP-HP], Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), École pratique des hautes études (EPHE)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)

المصدر: Journal of Infectious Diseases
Journal of Infectious Diseases, 2017, 215 (8), pp.1331-1338. ⟨10.1093/infdis/jix143⟩
Journal of Infectious Diseases, Oxford University Press (OUP), 2017, 215 (8), pp.1331-1338. ⟨10.1093/infdis/jix143⟩

مصطلحات موضوعية: Male, 0301 basic medicine, Complement Membrane Attack Complex, Neisseria meningitidis, MESH: Virulence, MESH: Meningococcal Infections, medicine.disease_cause, [SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, MESH: Child, Immunology and Allergy, complement, terminal complement pathway, Child, Complement Activation, Virulence, MESH: Genetic Testing, MESH: Paris, 3. Good health, Infectious Diseases, Female, Terminal complement pathway deficiency, Paris, Adolescent, MESH: Complement Activation, membrane attack complex, Biology, primary immunodeficiency, MESH: Neisseria meningitidis, 03 medical and health sciences, MESH: Complement Membrane Attack Complex, medicine, Humans, Genetic Testing, Gene, Retrospective Studies, MESH: Adolescent, MESH: Humans, MESH: Retrospective Studies, medicine.disease, Virology, MESH: Male, Complement system, Meningococcal Infections, 030104 developmental biology, Carriage, [SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics, Primary immunodeficiency, Complement membrane attack complex, MESH: Female

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6223d5e1ce2ebea5247f5be4f03a9f9Test
https://doi.org/10.1093/infdis/jix143Test

المؤلفون: Christian Merle, Eva Hong, Ibrahim Mounchetrou Njoya, Daniel Lévy-Bruhl, Anne-Sophie Barret, Muhamed-Kheir Taha, Clément Bassi

المساهمون: CIRE- Ile de France, Centre National de Référence des Méningocoques et Haemophilus influenzae - National Reference Center Meningococci and Haemophilus influenzae (CNR), Institut Pasteur [Paris], Agence Régionale de la Santé (ARS), Santé publique France - French National Public Health Agency [Saint-Maurice, France], We wish to thank Asmahan Batapou and Léoine Pierre, members of Public Health unit of the Health Agency in the Ile-de-France region and Annie-Claude Paty, member of the French Institute for Public Health Surveillance, who helped us to collect information. We are also grateful for the genomic platform PIBNEt-P2M of the Institut Pasteur. The publication also made use of the Meningitis Research Foundation Meningococcus Genome Library (http://www.meningitis.org/research/genomeTest) developed by Public Health England, the Wellcome Trust Sanger Institute and the University of Oxford as a collaboration., Institut Pasteur [Paris] (IP)

المصدر: Eurosurveillance
Eurosurveillance, European Centre for Disease Prevention and Control, 2017, 22 (28), pii=30574. ⟨10.2807/1560-7917.ES.2017.22.28.30574⟩
Eurosurveillance, 2017, 22 (28), pii=30574. ⟨10.2807/1560-7917.ES.2017.22.28.30574⟩

مصطلحات موضوعية: Male, 0301 basic medicine, Epidemiology, MESH: Meningococcal Infections/blood, Neisseria meningitidis, medicine.disease_cause, MESH: Genotype, Molecular typing, 0302 clinical medicine, Medicine, 030212 general & internal medicine, cluster, MESH: Molecular Typing, Neisseria meningitidis serogroup, MESH: Paris, South American/UK strain, 3. Good health, MESH: Meningococcal Infections/diagnosis, MESH: Neisseria meningitidis, Serogroup W-135/isolation & purification, Vaccination, Invasive meningococcal disease, MESH: Young Adult, South american, MESH: Whole Genome Sequencing, Rapid Communication, Paris, Fever, Genotype, education, MESH: Meningococcal Infections/microbiology, 030106 microbiology, Serogroup, Disease cluster, Microbiology, MESH: Contact Tracing, Young Adult, 03 medical and health sciences, Neisseria meningitidis, Serogroup W-135, university, Virology, Humans, serogroup W, Students, MESH: Humans, Whole Genome Sequencing, MESH: Neisseria meningitidis, Serogroup W-135/genetics, business.industry, invasive meningococcal disease, Public Health, Environmental and Occupational Health, MESH: Serogroup, MESH: Fever/etiology, MESH: Male, Meningococcal Infections, Molecular Typing, MenACWY conjugate vaccine, MESH: Students, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Contact Tracing, business, Contact tracing

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47c67ab5790bf9e69ee6b6631ece2fa0Test
https://doi.org/10.2807/1560-7917.es.2017.22.28.30574Test

المؤلفون: Pierre Chauvin, Véronique Massari, Sandrine Halfen, Annabelle Lapostolle, Nathalie Beltzer

المساهمون: ESIM - Déterminants Sociaux de la Santé et du Recours aux Soins (DS3), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Connaissances, attitudes, croyances et comportements (KABP), Observatoire régional de santé Ile-de-France HIV/sida (ORS), Lapostolle, Annabelle

المصدر: Journal of Immigrant and Minority Health
Journal of Immigrant and Minority Health, Springer Verlag, 2013, 15 (4), pp.842-5. ⟨10.1007/s10903-012-9742-z⟩
Journal of Immigrant and Minority Health, 2013, 15 (4), pp.842-5. ⟨10.1007/s10903-012-9742-z⟩

مصطلحات موضوعية: Adult, Male, Paris, medicine.medical_specialty, Adolescent, Epidemiology, MESH: Africa, Northern, MEDLINE, Emigrants and Immigrants, HIV Infections, Hiv testing, Article, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Hiv test, Africa, Northern, medicine, Humans, Mass Screening, MESH: Mass Screening, 030212 general & internal medicine, Young adult, Aged, MESH: Adolescent, MESH: Aged, MESH: Middle Aged, MESH: Humans, 030505 public health, Public health, MESH: Paris, Public Health, Environmental and Occupational Health, MESH: Adult, MESH: HIV Infections, Middle Aged, MESH: Emigrants and Immigrants, Metropolitan area, MESH: Male, Geography, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, MESH: Young Adult, Cohort, Nationality, Female, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, 0305 other medical science, MESH: Female, Demography

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb43db1d5b305a05ed598c3ba461f422Test
https://doi.org/10.1007/s10903-012-9742-zTest